. Third COVID vaccine candidate starts phase 3 trial in US - IOPAC Press "Enter" to skip to content

International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats
- All WHO news
The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to...
The first-ever global oral health conference highlights universal health coverage by 2030
- All WHO news
Delegations from over 110 countries are coming together to produce national roadmaps and negotiate a joint declaration on oral health...
Lebanon: a conflict particularly destructive to health care
- All WHO news
Since 7 October 2023, 47% of attacks on health care – 65 out of 137 – have proven fatal to...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Third COVID vaccine candidate starts phase 3 trial in US

By iopac on September 1, 2020

Stephanie Soucheray | News Reporter | CIDRAP NewsSep 01, 2020AstraZeneca plans to test its vaccine in 30,000 healthy adults.

Published in COVID-19

iopac